NA
LUNG icon

NewEdge Advisors’s Pulmonx LUNG Stock Holding History

NewEdge Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$162 – 4324
2025
Q3 		$162 Hold
100
– – ﹤0.01% 4017
2025
Q2 		$259 Hold
100
– – ﹤0.01% 3865
2025
Q1 		$673 Hold
100
– – ﹤0.01% 3673
2024
Q4 		$679 Hold
100
– – ﹤0.01% 3622
2024
Q3 		$829 Hold
100
– – ﹤0.01% 3547
2024
Q2 		$634 Hold
100
– – ﹤0.01% 3539
2024
Q1 		$927 Hold
100
– – ﹤0.01% 3516
2023
Q4 		$1.27K Hold
100
– – ﹤0.01% 3419
2023
Q3 		$1.03K Hold
100
– – ﹤0.01% 3168
2023
Q2 		$1.31K Hold
100
– – ﹤0.01% 3194
2023
Q1 		$1.12K Sell
100
-1,900
-95% -$18.8K ﹤0.01% 3140
2022
Q4 		$16.9K Buy
+2,000
New +$19K ﹤0.01% 2178

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors's LUNG Position: Q4 2025 in Review

NewEdge Advisors sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 100 shares — an estimated $162 sold.

NewEdge Advisors first reported a position in LUNG in Q4 2022 and held it in 12 quarters. The position peaked at $16.9K in Q4 2022. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • NewEdge Advisors reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • NewEdge Advisors sold 100 Pulmonx shares in Q4 2025, an estimated $162.
  • NewEdge Advisors first reported a position in Pulmonx in Q4 2022 and held it in 12 quarters.
  • NewEdge Advisors's Pulmonx position peaked at $16.9K in Q4 2022.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.